- Home
- PLYA vs MDXG Comparison
PLYA vs MDXG Comparison
Compare PLYA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYA
- MDXG
- Stock Information
- Founded
- PLYA 2006
- MDXG 2006
- Country
- PLYA Netherlands
- MDXG United States
- Employees
- PLYA N/A
- MDXG N/A
- Industry
- PLYA Hotels/Resorts
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- PLYA Consumer Discretionary
- MDXG Health Care
- Exchange
- PLYA Nasdaq
- MDXG Nasdaq
- Market Cap
- PLYA 1.2B
- MDXG 1.1B
- IPO Year
- PLYA N/A
- MDXG N/A
- Fundamental
- Price
- PLYA $9.72
- MDXG $9.24
- Analyst Decision
- PLYA Strong Buy
- MDXG Strong Buy
- Analyst Count
- PLYA 5
- MDXG 5
- Target Price
- PLYA $11.40
- MDXG $12.00
- AVG Volume (30 Days)
- PLYA 1.2M
- MDXG 1.1M
- Earning Date
- PLYA 11-06-2024
- MDXG 10-30-2024
- Dividend Yield
- PLYA N/A
- MDXG N/A
- EPS Growth
- PLYA 106.66
- MDXG N/A
- EPS
- PLYA 0.49
- MDXG 0.52
- Revenue
- PLYA $949,669,000.00
- MDXG $342,804,000.00
- Revenue This Year
- PLYA N/A
- MDXG $9.56
- Revenue Next Year
- PLYA $2.21
- MDXG $9.19
- P/E Ratio
- PLYA $19.85
- MDXG $18.32
- Revenue Growth
- PLYA 0.71
- MDXG 10.93
- 52 Week Low
- PLYA $6.95
- MDXG $5.47
- 52 Week High
- PLYA $10.13
- MDXG $9.49
- Technical
- Relative Strength Index (RSI)
- PLYA 69.35
- MDXG 81.04
- Support Level
- PLYA $9.25
- MDXG $8.55
- Resistance Level
- PLYA $10.13
- MDXG $9.49
- Average True Range (ATR)
- PLYA 0.25
- MDXG 0.40
- MACD
- PLYA -0.01
- MDXG 0.15
- Stochastic Oscillator
- PLYA 73.55
- MDXG 96.72
About PLYA Playa Hotels & Resorts N.V.
Playa Hotels & Resorts NV acts as an owner, operator, and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. The company's segments are Yucatan Peninsula, Pacific Coast, Dominican Republic, and Jamaica. It generates a majority of its revenue from the Yucatan Peninsula segment. Its brand profile consists of HYATT ZIVA, HYATT ZILARA, Hilton, JEWEL RESORTS, and others.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.